The Cooper Companies (COO) Financials: History & Chart

The Cooper Companies, Inc. (COO)COOThe Cooper Companies, Inc.

About The Cooper Companies, Inc.

The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.

San Ramon, CA

15,000 employees

www.coopercos.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Albert G. White

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Apr 2026	Quarter ended Jan 2026	Quarter ended Oct 2025	Quarter ended Jul 2025	Quarter ended Apr 2025	Quarter ended Jan 2025	Quarter ended Oct 2024	Quarter ended Jul 2024
Revenue	4.23B	1.08B	1.02B	1.07B	1.06B	1.00B	964.70M	1.02B	1.00B
Cost of Goods Sold	1.51B	346.10M	328.90M	464.20M	368.30M	323.20M	304.50M	340.70M	339.80M
Gross Profit	2.72B	735.40M	695.20M	601.00M	692.00M	679.10M	660.20M	677.70M	663.00M
Gross Profit Margin	64.4%	68.0%	67.9%	56.4%	65.3%	67.8%	68.4%	66.5%	66.1%
Total Operating Expenses	2.23B	766.40M	482.40M	460.60M	516.30M	494.30M	478.20M	479.30M	470.50M
Research & Development	172.80M	42.50M	44.30M	41.40M	44.60M	45.50M	40.70M	37.70M	39.00M
Selling, General & Administrative	1.91B	676.20M	390.20M	419.20M	421.70M	399.00M	387.90M	391.40M	381.10M
Operating Income (EBIT)	497.90M	-31.00M	212.80M	140.40M	175.70M	184.80M	182.00M	198.40M	192.50M
Operating Margin	11.8%	-2.9%	20.8%	13.2%	16.6%	18.4%	18.9%	19.5%	19.2%
Income Before Tax (EBT)	412.50M	-48.40M	192.20M	116.80M	151.90M	144.50M	153.30M	168.60M	163.70M
Interest Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	93.10M	20.90M	22.40M	24.40M	25.40M	33.30M	26.00M	27.00M	28.50M
Other Income/Expense	-85.40M	-17.40M	-20.60M	-23.60M	-23.80M	-40.30M	-28.70M	-29.80M	-28.80M
Net Income	235.80M	-77.90M	130.80M	84.60M	98.30M	87.70M	104.30M	117.50M	104.70M
Income Tax Expense	176.70M	29.50M	61.40M	32.20M	53.60M	56.80M	49.00M	51.10M	59.00M
Net Profit Margin	5.6%	-7.2%	12.8%	7.9%	9.3%	8.7%	10.8%	11.5%	10.4%
EBITDA	882.60M	64.40M	308.30M	238.80M	271.10M	277.40M	273.00M	289.40M	281.50M
EBITDA Margin	20.9%	6.0%	30.1%	22.4%	25.6%	27.7%	28.3%	28.4%	28.1%
Depreciation & Amortization	384.70M	95.40M	95.50M	98.40M	95.40M	92.60M	91.00M	91.00M	89.00M
EPS Basic	1.18	-0.40	0.66	0.43	0.49	0.44	0.52	0.59	0.53
EPS Diluted	1.18	-0.40	0.66	0.43	0.49	0.44	0.52	0.58	0.52
Shares Outstanding	195.00M	195.00M	196.70M	198.10M	200.60M	199.90M	201.20M	201.10M	199.10M
Diluted Shares Outstanding	195.00M	195.00M	196.70M	198.10M	200.60M	200.70M	201.20M	201.10M	200.60M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	10/31/2025	10/31/2024	10/31/2023	10/31/2022	10/31/2021	10/31/2020	10/31/2019	10/31/2018
Revenue	4.09B	3.90B	3.59B	3.31B	2.92B	2.43B	2.65B	2.53B
Cost of Goods Sold	1.61B	1.30B	1.24B	1.17B	966.70M	896.10M	896.60M	900.50M
Gross Profit	2.48B	2.60B	2.36B	2.14B	1.96B	1.53B	1.76B	1.63B
Gross Profit Margin	60.7%	66.6%	65.6%	64.7%	66.9%	63.1%	66.2%	64.4%
Total Operating Expenses	1.80B	1.89B	1.82B	1.63B	1.45B	1.22B	1.23B	1.20B
Research & Development	172.20M	155.10M	137.40M	110.30M	92.70M	93.30M	86.70M	84.80M
Selling, General & Administrative	1.63B	1.53B	1.50B	1.34B	1.21B	992.50M	996.60M	973.30M
Operating Income (EBIT)	682.90M	705.70M	533.10M	507.60M	505.80M	311.80M	546.70M	403.10M
Operating Margin	16.7%	18.1%	14.8%	15.3%	17.3%	12.8%	20.6%	15.9%
Income Before Tax (EBT)	566.50M	582.30M	412.90M	475.30M	491.50M	266.50M	477.40M	331.90M
Interest Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	100.00M	114.30M	105.30M	57.30M	23.10M	36.80M	68.00M	82.70M
Other Income/Expense	-116.40M	-123.40M	-120.20M	-32.30M	-14.30M	-45.30M	-91.40M	-71.20M
Net Income	374.90M	392.30M	294.20M	385.80M	2.94B	238.40M	466.70M	139.90M
Income Tax Expense	191.60M	190.00M	118.70M	89.50M	-2.45B	28.10M	10.70M	192.00M
Net Profit Margin	9.2%	10.1%	8.2%	11.7%	100.8%	9.8%	17.6%	5.5%
EBITDA	1.11B	1.08B	900.80M	853.70M	815.10M	598.90M	827.50M	678.20M
EBITDA Margin	27.0%	27.7%	25.1%	25.8%	27.9%	24.6%	31.2%	26.8%
Depreciation & Amortization	423.00M	375.10M	367.70M	346.10M	309.30M	287.10M	280.80M	275.10M
EPS Basic	1.88	1.97	1.49	1.96	59.73	4.86	9.47	2.85
EPS Diluted	1.87	1.96	1.48	1.94	59.07	4.81	9.32	2.81
Shares Outstanding	200.00M	198.90M	198.00M	197.20M	197.20M	196.40M	197.20M	196.40M
Diluted Shares Outstanding	200.00M	200.40M	199.20M	198.80M	199.40M	198.20M	200.20M	198.80M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.